VPH Leadership continues into 2027
We are pleased to present the 2027 Board of Directors of the VPH Society, appointed during the recent GA in Milan to guide the Society’s strategic priorities and initiatives in the year ahead.
Building on the continuity of the previous terms, the 2027 Board brings together experts from leading academic, clinical, research, and health technology assessment organisations across Europe and beyond. The Board will continue to support the Society’s mission to advance in silico medicine and strengthen collaboration across research, healthcare, technology and innovation.
The recently confirmed 2027 Board members are:
- Agència de Qualitat i Avaluació Sanitàries de Catalunya (Spain) – Rossana Alessandrello
- Great Ormond Street Hospital for Children (UK) – Claudio Capelli
- University of Amsterdam (Netherlands) – Alfons Hoekstra
- KU Leuven (Belgium) – Ilse Jonkers
- University of Sheffield (UK) – Damien Lacroix
- Sano (Poland) – Maciej Malawski
- University of Bologna (Italy) – Sabato Mellone
- University of Catania (Italy) – Francesco Pappalardo
- University of Auckland (New Zealand) – Merryn Tawhai
- Inria (France) – Irene Vignon-Clementel
The continued involvement of this experienced group provides a strong foundation for the Society’s work in 2027. The Board of Directors plays a central role in defining the Society’s strategic priorities, overseeing its general affairs, and supporting initiatives that advance the development and adoption of in silico medicine.
We look forward to working with the 2027 Board and our wider community to further strengthen collaboration, foster innovation, and contribute to the continued development of in silico medicine worldwide.
Related news
From algorithms to headlines: Media coverage of in silico medicine over the past 10 years
How has the media portrayed in silico medicine over the past decade? A new VPH study analyses 10 years of coverage across six countries, revealing a growing focus on AI and significant differences in how newspapers balance technological promises with risks and implications.
VPH2026 brings together 650 experts in Milan to advance in silico medicine
A record 650 participants gathered in Milan to exchange knowledge, foster collaboration and explore the future of in silico medicine.
Meet the new Young Scientists Committee (2027-2028)
During the closing ceremony of its 2026 Conference, VPH announced its largest-ever Young Scientists Committee, which will begin its two-year mandate in January 2027, strengthening opportunities for engagement, support, and representation of early-career researchers.
